Canadian Bioceutical reports revenue up 14%

Canadian Bioceutical reports revenue up 14%

The Canadian Bioceutical Corporation (CSE:BCC) (OTC:CBICF), the Toronto-based operator of cannabis facilities, primarily operating in the USA, reported financial results for the first quarter of its 2018 fiscal year, ending June 30, 2017. Revenue was up 14% from the...